Product ID |
Product Name |
CAS# |
Purity |
Y3116233 |
(3-Bromo-2-ethoxyphenyl)(methyl)sulfane |
2379321-50-1 |
95% |
Y3295577 |
N-(3-Oxotetradecanoyl)-DL-homoserinelactonemin97% |
503610-29-5 |
95% |
Y3119477 |
2-Fluoro-4,5-dimethylphenylboronic acid |
1125394-25-3 |
95% |
Y3296166 |
GNE-5729 |
2026635-66-3 |
99% |
Y3286146 |
Cy3 NHS ester |
2632339-91-2 |
95% |
Y3118158 |
ACT-451840 |
1984890-99-4 |
96.45% |
Y1247430 |
BI-4020 |
2664214-60-0 |
98% |
Y3114684 |
2H-Pyran-4-amine, 4-ethynyltetrahydro-, 2,2,2-trifluoroacetate (1:1) |
2503206-59-3 |
95% |
Y3114685 |
3-(4-Methoxyphenyl)-3-methylpyrrolidine Hydrochloride |
2624135-46-0 |
95% |
Y3317829 |
3-Cyanopyridine N-oxide |
149060-64-0 |
95+% |
Y1251856 |
(R)-2-Amino-2-phenylpropan-1-ol hydrochloride |
31917-23-4 |
95% |
Y3114619 |
rac-(3S,4R)-3-Methyl-4-piperidinol hydrochloride |
955028-94-1 |
95% |
Y3111950 |
[1-(4-Methylphenyl)-1H-1,2,3-triazol-4-yl]methanol |
875658-14-3 |
95% |
Y3294800 |
Methyl2-amino-2-furanacetatehydrochloride |
869556-76-3 |
95% |
Y3312616 |
1-Bromo-2,4-di-tert-butylbenzene |
80438-66-0 |
95% |
Y1291457 |
9,9'-(6-Chloro-1,3,5-triazine-2,4-diyl)bis(9H-carbazole) |
877615-05-9 |
97% |
Y1333802 |
2-Bromo-[1,1'-biphenyl]-4-ol |
15460-07-8 |
95% |
Y3310640 |
2-(Benzo[d]thiazol-2-yl)-4-bromophenol |
6344-17-8 |
95% |
Y3112120 |
p-Toluic Acid-d7 |
1219798-76-1 |
95% |
Y3318678 |
7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione |
2253964-85-9 |
95%+ |
Y3297022 |
Difloxacin-d3 Hydrochloride Salt |
1173021-89-0 |
99% |
Y1318809 |
N-Formyl Erythromycin A (>90%) |
127955-44-6 |
95% |
Y3312698 |
4-(4-Methylbenzyl)-4-thiazinane-1,1-dione |
477858-35-8 |
98% |
Y1256236 |
Nintedanib Acetyl Impurity |
1139458-48-2 |
98% |
Y3108793 |
2,4-bis(4-(tert-butyl)phenyl)-6-chloro-1,3,5-triazine |
253158-13-3 |
98% |
Y3119474 |
(4-Bromo-2-chloro-5-fluorophenyl)boronic acid |
2225155-64-4 |
95% |
Y1246913 |
Pomalidomide-amino-PEG4-NH2 hydrochloride |
2331259-45-9 |
99% |
Y3122766 |
AT-9010 tetrasodium |
1621884-18-1 |
99% |
Y3292270 |
L-Carnosine-d4 |
2714339-90-7 |
95% |
Y3297118 |
Sulfamethizole-d4 |
2470130-12-0 |
95% |
Y3316758 |
(3R,5S)-5-((S)-8-fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5-dihydroxypentanoate calcium(II) |
854898-50-3 |
95% |
Y1238652 |
allyl 5-(4-(hydroxymethyl)phenoxy)pentanoate |
1642310-00-6 |
95% |
Y1234314 |
4,5-DIHYDRO-1H-PYRAZOLO[3,4-F]QUINOLINE-3-CARBOXYLIC ACID |
1147417-01-3 |
96% |
Y1234361 |
3-PHENYL-INDOLIZINE-1-CARBOXYLIC ACID |
92497-75-1 |
95% |
Y1243189 |
(E)-ethyl 2-(3-oxoisobenzofuran-1(3H)-ylidene)acetate |
57691-07-3 |
95% |
Y1238629 |
N-(2-Hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl)-N-isopropylformamide |
1447715-45-8 |
97% |
Y3111946 |
N-[4-(2-Pyrimidinyloxy)phenyl]acetamide |
24550-10-5 |
95% |
Y3313978 |
1,3,5,7-Tetramethyl-8-(2-di-o-tolylphosphinophenyl)-2,4,6-trioxa-8-phosphaadamantanePAd-DalPhos |
1902911-38-9 |
95% |
Y3290443 |
1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazol-4-amine |
1313520-72-7 |
95% |
Y1234346 |
2,6-Dibromo-4-(1,1-dimethylpropyl)phenol |
34593-79-8 |
95%+ |
Y3112000 |
6-(4-Methylstyryl)-3(2H)-pyridazinone |
83516-66-9 |
95% |
Y3110436 |
(4-(Difluoromethoxy)naphthalen-1-yl)methanol |
668275-85-2 |
95% |
Y1234364 |
Palbociclib Impurity 025 |
2174002-16-3 |
97% |
Y3310683 |
LTßR-IN-1 |
2189366-77-4 |
99% |
Y3312881 |
TRV120056 |
40678-47-5 |
99.89% |
Y3116518 |
5-Chloro-4-iodo-2-ethoxypyridine |
2056110-48-4 |
95% |
Y3116512 |
(2'-Chloro-[1,1'-biphenyl]-2-yl)boronic acid |
2209082-58-4 |
98% |
Y3286173 |
2-[2-(4-fluorophenyl)ethyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
1065498-70-5 |
95% |
Y3106554 |
7-Bromothieno[3,2-c]pyridine |
1535297-40-5 |
95% |
Y3317725 |
5-(Benzyloxy)-3-hydroxymethylpyridine |
875755-69-4 |
95% |
Y3112083 |
(±)-Ketoconazole-d4 (piperazine-3,3,5,5-d4) |
1398065-75-2 |
98% |
Y3116707 |
ZX-29 |
2254805-62-2 |
98% |
Y1314532 |
[1,1:3,1-Terphenyl]-4,4-dicarboxylic acid,5-methyl- |
1582811-97-9 |
98% |
Y3118314 |
Pomalidomide-PEG6-COOH |
2225148-49-0 |
98% |
Y3112051 |
(1R,4R)-4-fluoro-4-methylcyclohexan-1-amine hydrochloride |
2361595-27-7 |
95% |
Y1338401 |
7H-Spiro[furo[3,4-b]pyridine-5,4'-piperidine] |
1036408-86-2 |
95% |
Y1238630 |
3,5-dibromo-N-methylpyridin-2-amine |
858839-25-5 |
97% |
Y3286060 |
N-Benzyl-N-methyl-L-phenylalaninemethylesterhydrochloride |
1948241-07-3 |
99% (HPLC) |
Y3112056 |
4-Chloro-5-iodo-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine |
1207543-30-3 |
95% |
Y1332374 |
4,5-Dibromo-1H-indole |
1227571-79-0 |
95% |
Y1303165 |
2-Amino-3-fluoro-5-methylbenzoic acid |
1039900-47-4 |
95% |
Y3112010 |
6-phenyl-3-azabicyclo[3.2.0]heptane hydrochloride, Mixture of diastereomers |
2137987-26-7 |
95% |
Y3111964 |
tert-Butyl (S)-pyrrolidine-3-carboxylate hydrochloride |
2241577-71-7 |
95% |
Y1238661 |
N-Methyl-5-isoquinolinamine |
1341688-75-2 |
97% |
Y3111951 |
tert-Butyl-(R)-pyrrolidine-3-carboxylate hydrochloride |
2710510-52-2 |
95% |
Y3293789 |
MT-4 |
2327925-35-7 |
98% |
Y1243192 |
PDE12-IN-3 |
1803357-22-3 |
99% |
Y1313642 |
2- (N'-Benzoyltioureido) -3-Ethoxycarbonyl-5,5-Dimethyl-5,7-Dihydro-4h-Thieno [2,3-C] Pyran |
314042-00-7 |
97% |
Y3317618 |
Methyl 2- (chloromethyl) Isonicotinate Hydrochloride |
125398-17-6 |
97% |
Y1314488 |
2-Thiophen-2-YL-Thiazole-4-Carboxylic Acid Methyl Ester |
1489464-15-4 |
98% |
Y3112839 |
1,1'-(6,7,9,10,17,18,20,21-Octahydrodibenzo[ b,k][1,4,7,10,13,16]hexaoxacyclooctadecine-2 ,14-diyl)bis(ethan-1-one) |
67722-65-0 |
98% |
Y1243193 |
5-Amino-3-((4-bromo-2,6-difluorobenzyl)oxy)isothiazole-4-carboxamide |
2436737-00-5 |
98% |
Y1238684 |
N-(2-Chloroethyl)-3-cyanobenzamide |
1247759-33-6 |
97% |
Y3316630 |
Methyl 2-(4-(dimethylamino)phenyl)-2-hydroxyacetate |
1310720-83-2 |
97% |
Y3313070 |
Acetamide, N-(4-bromo-3,5-dimethylphenyl)-2,2,2-trifluoro- |
306297-11-0 |
97% |
Y3113738 |
3-Bromo-6-fluoro-2-hydrazineylpyridine |
2375259-09-7 |
95% |
Y1238703 |
(1S,2S)-2-((Benzyloxy)methyl)cyclopropane-1-carboxylic acid |
1932779-15-1 |
95% |
Y1243194 |
(1R,2R)-2-((Benzyloxy)methyl)cyclopropanecarboxylic acid |
561055-27-4 |
95% |
Y1247566 |
TERT-BUTYL 4-(6-AMINOPYRIDAZIN-3-YL)PIPERIDINE-1-CARBOXYLATE |
1426921-48-3 |
95% |
Y3294424 |
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfonyl]benzamide |
1348536-59-3 |
95% |
Y1247567 |
Ethyl 2-(methylamino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate |
893005-88-4 |
97% |
Y3308052 |
Tadalafil Impurity D |
951661-81-7 |
95% |
Y3285820 |
IDH1 Inhibitor 1 |
2234285-81-3 |
99% |
Y3114560 |
1,1-Difluorobutan-2-one |
136400-33-4 |
95% |
Y3114572 |
3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,6-dimethylbenzoic acid |
2138194-85-9 |
95% |
Y1250242 |
(4-Amino-3-methoxyphenyl)dimethylphosphine oxide |
1197956-03-8 |
95% |
Y1241484 |
(R)-2-(6-Methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole |
199277-73-1 |
97% |
Y3318436 |
5-Bromo-2-chloro-1,3-diiodobenzene |
2383588-60-9 |
95% |
Y1254675 |
4',4'''-(2,2-Diphenylethene-1,1-diyl)bis([1,1'-biphenyl]-4-carbaldehyde) |
2131097-89-5 |
97% |
Y1245825 |
8-Bromo-3-methyl-3,5,6,7-tetrahydro-2H-indeno[5,6-b]furan |
2676863-82-2 |
97% |
Y1250221 |
2,2'-((2,2-Diphenylethene-1,1-diyl)bis(4,1-phenylene))bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) |
1447669-03-5 |
97% |
Y1254678 |
5-(Trifluoromethyl)-5H-thianthren-5-ium tetrafluoroborate |
2648079-80-3 |
95% |
Y1250243 |
2,6-Bis(N-pyrazolyl)pyridine nickel(II) bromide |
1132833-41-0 |
98% |
Y1289599 |
5,5-Dimethyl-2-(phenanthren-9-yl)-1,3,2-dioxaborinane |
1416371-19-1 |
97% |
Y1313016 |
rel-Methyl (3aS,6aR)-5-benzylhexahydro-3aH-furo[2,3-c]pyrrole-3a-carboxylate |
2696257-39-1 |
97% |
Y3110146 |
3-Amino-[1,1'-biphenyl]-4,4'-dicarboxylic acid |
1369287-06-8 |
97% |
Y1245917 |
1,3-Bis((3aS,8aR)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)benzene |
175733-74-1 |
97% |
Y1258971 |
2-Bromo-7-phenyl-9H-carbazole |
1656983-56-0 |
95% |
Y1315401 |
4-Methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-N-(p-tolyl)aniline |
528610-00-6 |
98% |
Y1250254 |
5-Cyclopropyl-2,3-dihydro-1H-inden-4-amine |
2676863-72-0 |
97% |